LS
TCRT icon

Lupo Securities’s Alaunos Therapeutics TCRT Stock Holding History

Lupo Securities’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$32K Buy
24
+1
+4% +$1.65K 0.24% 41
2015
Q2 		$41K Buy
23
+6
+35% +$9.31K 0.16% 36
2015
Q1 		$28K Buy
+17
New +$25.2K 0.04% 195

Other funds holding TCRT

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lupo Securities's TCRT Position: Q3 2015 in Review

Lupo Securities increased its Alaunos Therapeutics (TCRT) stake by 4.3% in Q3 2015, buying an estimated $1.65K and bringing the position to 24 shares worth $32K. The position accounts for 0.24% of the portfolio, ranked #41.

Lupo Securities first reported a position in TCRT in Q1 2015 and has held it in 3 quarters since. The position peaked at $41K in Q2 2015. 138 funds tracked by Wall St. Rank hold TCRT as of Q3 2015.

  • Lupo Securities held 24 shares of Alaunos Therapeutics worth $32K as of Q3 2015.
  • Lupo Securities bought 1 Alaunos Therapeutics share in Q3 2015, an estimated $1.65K.
  • Alaunos Therapeutics made up 0.24% of Lupo Securities's portfolio in Q3 2015, its #41 holding.
  • Lupo Securities first reported a position in Alaunos Therapeutics in Q1 2015 and has held it in 3 quarters since.
  • Lupo Securities's Alaunos Therapeutics position peaked at $41K in Q2 2015.
  • 138 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.